Identification of metabolomics biomarkers for type 2 diabetes: triangulating evidence from longitudinal and Mendelian randomization analyses
Preprint
Abstract
The number of people affected by Type 2 Diabetes Mellitus (T2DM) is close to half a billion and is on a sharp rise, representing a major and growing public health burden. As the case for many other complex diseases, early diagnosis is key to prevent irreversible end-organ damages. However, given its mild initial symptoms, T2DM is often diagnosed several years after its onset, leaving half of diabetic individuals undiagnosed. While several classical clinical and genetic biomarkers have been identified, improving early diagnosis by exploring other kinds of omics data remains crucial. In this study, we have combined longitudinal data from two population-based cohorts CoLaus and DESIR (comprising in total 493 incident cases vs 1’360 controls) to identify new or confirm previously implicated metabolomic biomarkers predicting T2DM incidence more than five years ahead of clinical diagnosis. Our longitudinal data have shown robust evidence for valine, leucine, carnitine and glutamic acid being predictive of future conversion to T2DM, and also confirmed to be causal by 2-sample Mendelian randomisation (based on independent data). Interestingly, for valine and leucine a strong reverse causal effect was detected, indicating that the genetic predisposition to T2DM may trigger early changes of these metabolites, which appear well-before any clinical symptoms. These findings indicate that molecular traits linked to the genetic basis of T2DM may be particularly promising early biomarkers.Keywords
All Related Versions
- Published version: Scientific Reports, 11 (1), 1.
This publication has 49 references indexed in Scilit:
- Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic ApproachDiabetes, 2013
- Novel biomarkers for pre‐diabetes identified by metabolomicsMolecular Systems Biology, 2012
- Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in HumansCirculation, 2012
- Leucine signaling in the pathogenesis of type 2 diabetes and obesityWorld Journal of Diabetes, 2012
- Metabolite profiles and the risk of developing diabetesNature Medicine, 2011
- Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological SettingPLOS ONE, 2010
- A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitusPsychoneuroendocrinology, 2009
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Glutamate Is a Positive Autocrine Signal for Glucagon ReleaseCell Metabolism, 2008
- Determination of free L-carnitine levels in type II diabetic women with and without complicationsEuropean Journal of Clinical Nutrition, 2007